Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
TGTX —
TG THERAPEUTICS INC
CUSIP: 88322Q108 · Held by 2 superinvestors · Combined value: $62,317,567
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $48,311,189 | 1,620,637 | REDUCE | -62,666 |
| 2 | Ray Dalio | 0.1% | $14,006,378 | 469,855 | ADD | +127,706 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ray Dalio | ADD | +127,706 | +37.3% |
| Ken Griffin | REDUCE | -62,666 | -3.7% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ray Dalio | NEW BUY | +342,149 | New |
| Ken Griffin | REDUCE | -255,665 | -13.2% |
| Polen Capital | SOLD | -14,768 | Exit |
Who Owns TGTX? Superinvestor Holdings
TG THERAPEUTICS INC is held by 2 tracked superinvestors, with a combined position value of $62 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Ray Dalio (0.1% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions while 1 reduced or exited.